Tesamorelin requires consistent daily 2 mg subcutaneous injections
(Growth Hormone and IGF Research, 2003) reviewed peptide therapy approaches targeting the somatotropic axis and documented measurable shifts in body composition in subjects with growth hormone deficiency, including reductions in adipose tissue, improvements in lean muscle mass, positive changes in bone mineral parameters, and favorable metabolic marker changes
That puts me in an interesting position
It may support healthy melanin production
Over weeks and months, fat mass decreases while lean mass increases simultaneously
Best For Energy, recovery, healthy aging Method Subcutaneous Sermorelin peptide injection Frequency Nightly or as prescribed Eligibility for HSA or FSA reimbursement depends on your individual plan and medical necessity